Invention Grant
- Patent Title: 1,2,4-oxadiazole derivatives as liver X receptor agonists
-
Application No.: US17101510Application Date: 2020-11-23
-
Publication No.: US11427586B2Publication Date: 2022-08-30
- Inventor: Kelly D. Boss , Yi Fan , Alec Nathanson Flyer , Declan Hardy , Zhihong Huang , Kathryn Taylor Linkens , Jon Christopher Loren , Fupeng Ma , Valentina Molteni , Duncan Shaw , Jeffrey Smith , Catherine Fooks Solovay
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Asha K. Nadipuram
- Main IPC: C07D471/10
- IPC: C07D471/10 ; C07D413/14 ; C07D491/107 ; C07D413/06 ; A61P27/04
Abstract:
Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I′), or pharmaceutical composition described herein.
Public/Granted literature
- US20220064164A1 1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS Public/Granted day:2022-03-03
Information query
